K. Tung

Humoral antibody response to the first dose of the ChAdOx1 nCoV‐19 vaccine in Asian patients undergoing hemodialysis

C. Liao, Y. Chiu, Mei-Fen Pai, 2022, Hemodialysis international. International Symposium on Home Hemodialysis.

Risk factors for severe hypocalcemia after parathyroidectomy in prevalent dialysis patients with secondary hyperparathyroidism

Y. Chiu, Hung-Yuan Chen, Mei-Fen Pai, 2015, International Urology and Nephrology.

Adverse events following the first, second and third doses of a COVID-19 vaccine in hemodialysis patients

Y. Chiu, Mei-Fen Pai, Ju-Yeh Yang, 2023, Renal failure.

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Eddie B. S. Tan, Nishit P. Parikh, Rajan K. Patel, 2023, The Lancet.

Physician Compliance With a Computerized Clinical Decision Support System for Anemia Management of Patients With End-stage Kidney Disease on Hemodialysis: Retrospective Electronic Health Record Observational Study

Y. Chiu, Mei-Fen Pai, Ju-Yeh Yang, 2022, JMIR formative research.

Frequency of Early Predialysis Nephrology Care and Postdialysis Cardiovascular Events.

Jenq-Wen Huang, Likwang Chen, Mei-Fen Pai, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

N. Perico, M. Jardine, V. Perkovic, 2023, The Lancet.